3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
3
Uterine Cervical Neoplasms
1
Pancreatic Neuroendocrine Tumors (pNET)
1
Pancreatic Neoplasms
1
Lung Neoplasms
1
HER2 Negative Breast Cancer
1
Carcinoma, Non-Small-Cell Lung
1
Interventions
Temozolomide
37
Magnetic Resonance Spectroscopy
21
Radiotherapy
18
Specimen Handling
15
Radiation
10
Lomustine
9
Bevacizumab
8
pembrolizumab
7
fludarabine
5
Cyclophosphamide
5
Surgical Procedures, Operative
4
Nivolumab
4
Ipilimumab
4
Biopsy
4
olaparib
3
atezolizumab
3
Immunoglobulin G
3
Disulfides
3
Carboplatin
3
veliparib
2
trametinib
2
rocakinogene sifuplasmid
2
ribociclib
2
poly ICLC
2
pamiparib
2
niraparib
2
lutetium Lu 177 dotatate
2
gallium maltolate
2
durvalumab
2
dabrafenib
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Glioblastoma
×
Chemotherapy, Adjuvant
×
90 days
×
Clear all
No trials found.